Accessibility StatementSkip Navigation New U.S. data will offer first-of-its-kind evidence in patients with kidney failure DENVER, Oct. 20, 2025 /PRNewswire/ --Â DaVita today announced the launch of two groundbreaking initiatives aimed to deepen the medical community's understanding of middle-molecule removal and its potential to improve outcomes for patients with kidney failure. Research shows that when waste particles with larger molecular weight build up in the blood, patients may present higher inflamma ...